Hill-Rom Holdings Total Assets 2006-2018 | HRC

Hill-Rom Holdings total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Hill-Rom Holdings total assets for the quarter ending December 31, 2018 were $4.350B, a 2.47% decline year-over-year.
  • Hill-Rom Holdings total assets for 2018 were $4.36B, a 3.73% decline from 2017.
  • Hill-Rom Holdings total assets for 2017 were $4.529B, a 6.25% increase from 2016.
  • Hill-Rom Holdings total assets for 2016 were $4.262B, a 4.38% decline from 2015.
Hill-Rom Holdings Annual Total Assets
(Millions of US $)
2018 $4,360
2017 $4,529
2016 $4,262
2015 $4,458
2014 $1,751
2013 $1,587
2012 $1,628
2011 $1,299
2010 $1,246
2009 $1,233
2008 $1,690
2007 $2,117
2006 $1,952
2005 $2,229
Hill-Rom Holdings Quarterly Total Assets
(Millions of US $)
Q1 2018 $4,350
Q4 2018 $4,360
Q3 2018 $4,465
Q2 2018 $4,505
Q1 2017 $4,461
Q4 2017 $4,529
Q3 2017 $4,484
Q2 2017 $4,473
Q1 2016 $4,144
Q4 2016 $4,262
Q3 2016 $4,237
Q2 2016 $4,243
Q1 2015 $4,272
Q4 2015 $4,458
Q3 2015 $1,758
Q2 2015 $1,706
Q1 2014 $1,736
Q4 2014 $1,751
Q3 2014 $1,487
Q2 2014 $1,520
Q1 2013 $1,527
Q4 2013 $1,587
Q3 2013 $1,553
Q2 2013 $1,572
Q1 2012 $1,615
Q4 2012 $1,628
Q3 2012 $1,300
Q2 2012 $1,292
Q1 2011 $1,223
Q4 2011 $1,299
Q3 2011 $1,302
Q2 2011 $1,281
Q1 2010 $1,224
Q4 2010 $1,246
Q3 2010 $1,233
Q2 2010 $1,220
Q1 2009 $1,197
Q4 2009 $1,233
Q3 2009 $1,169
Q2 2009 $1,172
Q1 2008 $1,625
Q4 2008 $1,690
Q3 2008 $1,600
Q2 2008 $1,637
Q1 2007 $2,165
Q4 2007 $2,117
Q3 2007 $2,068
Q2 2007 $2,035
Q1 2006 $2,003
Q4 2006 $1,952
Q3 2006 $2,190
Q2 2006 $2,128
Q1 2005 $2,264
Q4 2005 $2,229
Q3 2005 $1,992
Q2 2005 $2,055
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.949B $2.470B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.272B 27.73
Medtronic (MDT) Ireland $125.787B 18.39
Stryker (SYK) United States $72.312B 26.54
Boston Scientific (BSX) United States $55.730B 27.17
Baxter (BAX) United States $39.435B 25.23
Zimmer Biomet Holdings (ZBH) United States $25.742B 16.48
Smith & Nephew SNATS (SNN) United Kingdom $17.346B 0.00
Canopy Growth (CGC) Canada $15.357B 0.00
ResMed (RMD) United States $14.383B 27.27
Aurora Cannabis (ACB) Canada $9.728B 68.64
Bio-Rad Laboratories (BIO) United States $9.298B 53.05
Perrigo (PRGO) Ireland $6.542B 10.61
Insulet (PODD) United States $5.812B 1960.80
GW Pharmaceuticals (GWPH) United Kingdom $5.107B 0.00
ICU Medical (ICUI) United States $4.771B 29.70
Haemonetics (HAE) United States $4.422B 39.23
Agios Pharmaceuticals (AGIO) United States $3.796B 0.00
Hutchison China MediTech (HCM) China $3.712B 0.00
Neogen (NEOG) United States $3.240B 49.77
NuVasive (NUVA) United States $2.859B 24.94
Quidel (QDEL) United States $2.688B 24.25
Aphria (APHA) $2.403B 106.67
National Vision Holdings (EYE) United States $2.385B 46.92
Cardiovascular Systems (CSII) United States $1.382B 992.25
Phibro Animal Health (PAHC) United States $1.275B 18.33
VAREX IMAGING (VREX) United States $1.255B 24.57
AtriCure (ATRC) United States $1.121B 0.00
MacroGenics (MGNX) United States $0.933B 0.00
Lantheus Holdings (LNTH) United States $0.929B 25.10
NanoString Technologies (NSTG) United States $0.855B 0.00
Cerus (CERS) United States $0.838B 0.00
PetIQ (PETQ) United States $0.787B 22.53
Omeros (OMER) United States $0.786B 0.00
OraSure Technologies (OSUR) United States $0.721B 31.62
Surmodics (SRDX) United States $0.703B 102.18
Meridian Bioscience (VIVO) United States $0.701B 20.89
Evolus (EOLS) United States $0.677B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.655B 22.28
LeMaitre Vascular (LMAT) United States $0.614B 29.22
TG Therapeutics (TGTX) United States $0.607B 0.00
Quanterix (QTRX) United States $0.552B 0.00
BioLife Solutions (BLFS) United States $0.346B 143.85
Vapotherm (VAPO) United States $0.335B 0.00
Utah Medical Products (UTMD) United States $0.323B 21.01
Insys Therapeutics (INSY) United States $0.308B 0.00
Owens & Minor (OMI) United States $0.301B 4.17
Rockwell Medical (RMTI) United States $0.297B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.269B 0.00
Bovie Medical (APYX) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.255B 0.00
Fonar (FONR) United States $0.146B 7.81
Zynex (ZYXI) United States $0.142B 15.14
Surface Oncology (SURF) United States $0.131B 0.00
Chimerix (CMRX) United States $0.104B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.094B 0.00
United-Guardian (UG) United States $0.089B 18.64
Conatus Pharmaceuticals (CNAT) United States $0.081B 0.00
Trinity Biotech (TRIB) Ireland $0.073B 21.79
CAS Medical Systems (CASM) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.026B 0.00
Capricor Therapeutics (CAPR) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14